La Jolla exits to Innoviva in a deal that caps 33 years marked by misses in lupus, malaria and beta thalassemia - Endpoints News

Thirty-three years after opening its doors and after many attempts at getting a lupus drug across the finish line, La Jolla Pharmaceutical is now wrapping into the Innoviva fold to give the acquirer two approved hospital drugs. La Jolla will be valued at abou…

Days after President Joe Biden signed an executive order directing HHS to expand access to birth control, HRA Pharma filed an application to become the first FDA-approved contraceptive pill available… [+704 chars]

full article...